Skip to Content

India’s 10-Year Patent Drive

The West begins licensing Indian-born inventions.
September 1, 2006

A decade after India launched an innovate-and-patent campaign, early signs of an Indian technology invasion are evident. Just two examples: a U.S. company has purchased the patent for ­Indian-­designed software that eliminates noise from complex digital data, and fruit growers in California and Turkey have bought a pomegranate deseeder invented by an Indian college dropout.

Illustration by Ken Orvidas

The patent portfolio of 38 publicly funded Indian laboratories has increased from fewer than 30 U.S. patents in 1995 to more than 720 in July of this year – and those patents are beginning to translate into licenses outside India. This growth reflects a dramatic transformation in India’s research culture. For decades, most research conducted within India’s closed economy was aimed at “reverse engineering” – a euphemism for copying technologies. “Without true innovation, we would always lag behind the best,” says Raghunath Mashelkar, director general of the network linking the 38 public labs, known as the Council of Scientific and Industrial Research, or CSIR.

After India opened its economy in the early 1990s, foreign products slipped in – from cars to cornflakes. Industries and scientists had to compete. In that changed environment, Mashelkar spearheaded a patent drive and preached a new mantra to scientists: “Patent, publish, and prosper.”

Now most scientists and labs select projects only when they see opportunities to generate intellectual property or acquire patents. Sometimes those opportunities lie in unexpected directions: one patented Indian technology – the digital noise filter – emerged because chemical engineer Bhaskar Kulkarni and his colleagues at the National Chemical Laboratory in Pune strayed off their home turf.

India’s patent savvy has also enticed global companies to exploit local Indian research talent and to seek partnerships with CSIR labs. To be sure, the raw patent numbers are quite small; they pale beside the track records of global corporate behemoths like IBM (more than 2,900 patents last year) or Samsung (more than 1,600). But Mashelkar says the CSIR’s labs, despite a fairly meager budget of approximately $330 million, are now garnering more U.S. patents than publicly funded laboratories in countries such as Germany, France, and Japan.

Of course, now that Cisco, Intel, General Electric, IBM, Sun Microsystems, and dozens of other companies have established Indian research centers, some fear that India’s potential intellectual property will increasingly flow to multinational companies. “They’re using Indian IQ to create IP for themselves,” says Mashelkar. “We need to exploit our local IQ to generate IP for ourselves.”

Nor is everyone happy with the tempo of licensing. The CSIR has licensed only 133 patents out of 1,915 granted. “The atmosphere for venture capital in high technology in India is not as good as it is in the United States,” says Ajay Sood, a physicist at the Indian Institute of Science in ­Bangalore. “The process of moving ideas from the laboratory to the marketplace needs to improve.”

But nothing is stopping the automated pomegranate deseeder. Unlike its predecessors, the gadget – designed by Uddhab Bharali, an engineering-­school dropout – does not require water to operate. As a result, “there is no dilution of fruit,” boasts Chinzah Lalmuanzuala, an official at the National Innovation Foundation, an agency trying to promote grassroots inventions.

Keep Reading

Most Popular

open sourcing language models concept
open sourcing language models concept

Meta has built a massive new language AI—and it’s giving it away for free

Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3

transplant surgery
transplant surgery

The gene-edited pig heart given to a dying patient was infected with a pig virus

The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.

Muhammad bin Salman funds anti-aging research
Muhammad bin Salman funds anti-aging research

Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging

The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.

Yann LeCun
Yann LeCun

Yann LeCun has a bold new vision for the future of AI

One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.